NO20060078L - Forbedrede elektrofysiologiske tester som benytter oocytter som uttrykker human ENaC og anvendelse av fenamil for a forbedre effekten av ENaC-forsterkere i tester som benytter membran potensial rapporterende fargestoffer - Google Patents

Forbedrede elektrofysiologiske tester som benytter oocytter som uttrykker human ENaC og anvendelse av fenamil for a forbedre effekten av ENaC-forsterkere i tester som benytter membran potensial rapporterende fargestoffer

Info

Publication number
NO20060078L
NO20060078L NO20060078A NO20060078A NO20060078L NO 20060078 L NO20060078 L NO 20060078L NO 20060078 A NO20060078 A NO 20060078A NO 20060078 A NO20060078 A NO 20060078A NO 20060078 L NO20060078 L NO 20060078L
Authority
NO
Norway
Prior art keywords
enac
tests
human
enhance
compounds
Prior art date
Application number
NO20060078A
Other languages
English (en)
Norwegian (no)
Inventor
Guy Servant
Hong Chang
Cyril Redcrow
Ray Sumita
Imran Clark
Original Assignee
Senomyx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senomyx Inc filed Critical Senomyx Inc
Publication of NO20060078L publication Critical patent/NO20060078L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/10—Applications; Uses in screening processes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
NO20060078A 2003-07-10 2006-01-05 Forbedrede elektrofysiologiske tester som benytter oocytter som uttrykker human ENaC og anvendelse av fenamil for a forbedre effekten av ENaC-forsterkere i tester som benytter membran potensial rapporterende fargestoffer NO20060078L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48574503P 2003-07-10 2003-07-10
PCT/US2004/021853 WO2005014848A2 (en) 2003-07-10 2004-07-09 IMPROVED ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES

Publications (1)

Publication Number Publication Date
NO20060078L true NO20060078L (no) 2006-04-07

Family

ID=34135067

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060078A NO20060078L (no) 2003-07-10 2006-01-05 Forbedrede elektrofysiologiske tester som benytter oocytter som uttrykker human ENaC og anvendelse av fenamil for a forbedre effekten av ENaC-forsterkere i tester som benytter membran potensial rapporterende fargestoffer

Country Status (12)

Country Link
US (5) US8105792B2 (ko)
EP (1) EP1644738A2 (ko)
JP (1) JP2007528712A (ko)
KR (1) KR20060029680A (ko)
CN (1) CN1842709A (ko)
AU (1) AU2004263845A1 (ko)
BR (1) BRPI0412471A (ko)
CA (1) CA2530497A1 (ko)
IL (1) IL172933A0 (ko)
MX (1) MXPA06000266A (ko)
NO (1) NO20060078L (ko)
WO (1) WO2005014848A2 (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10078087B2 (en) * 2001-05-01 2018-09-18 Senomyx, Inc. Assays and enhancers of the human delta ENaC sodium channel
WO2007092185A2 (en) * 2006-02-02 2007-08-16 Senomyx, Inc. Assays and enhancers of the human delta enac sodium channel
JP2007528712A (ja) * 2003-07-10 2007-10-18 セノミックス、インコーポレイテッド ヒトＥＮａＣを発現する卵母細胞を用いた改良された電気生理学的アッセイ及び膜電位リポーター色素を用いたアッセイにおけるＥＮａＣ相乗剤の効果を向上させるためのフェナミルの使用
EP2086992B1 (en) * 2006-10-19 2015-07-15 Monell Chemical Senses Center Human salty taste receptor and methods of modulating salty taste perception
EP2245057B1 (en) 2008-01-25 2019-09-04 Chromocell Corporation Novel cell lines expressing enac and methods using them
US20110003711A1 (en) * 2008-02-01 2011-01-06 Chromocell Corporation Cell lines expressing gaba receptor and methods using them
EP2278332A1 (en) 2009-07-20 2011-01-26 Fondazione Centro San Raffaele del Monte Tabor Method for optical measuring variations of cell membrane conductance
JP2012191850A (ja) * 2009-07-24 2012-10-11 Ajinomoto Co Inc インドール誘導体及び同誘導体を含有する塩味増強剤
EP3431604A1 (en) * 2010-04-23 2019-01-23 Arrowhead Pharmaceuticals, Inc. Organic compositions to treat beta-enac-related diseases
WO2012042621A1 (ja) * 2010-09-29 2012-04-05 味の素株式会社 塩味増強剤
JP6039891B2 (ja) * 2011-07-14 2016-12-07 花王株式会社 上皮型ナトリウムチャネル活性化剤
CN104964909B (zh) * 2015-05-28 2018-04-24 上海市血液中心 一种血小板跨膜电位检测方法
GB201719169D0 (en) * 2017-11-20 2018-01-03 Univ College Cardiff Consultants Ltd Novel T-cell receptor and ligand
CN109164158A (zh) * 2018-07-17 2019-01-08 中国科学院南京土壤研究所 电生理试验中记录微小电流的方法
CN109364248B (zh) * 2018-10-16 2021-05-18 哈尔滨医科大学 ENaC及其抑制剂在预防、缓解和/或治疗动脉粥样硬化中的应用
JP2022059100A (ja) * 2019-02-26 2022-04-13 味の素株式会社 ナトリウムの作用を調節する物質のスクリーニング方法
CN110530829A (zh) * 2019-08-20 2019-12-03 北京爱思益普生物科技股份有限公司 一种基于荧光的早期药物筛选方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693758A (en) 1987-11-19 1997-12-02 501 Research Corporation Limited Immunoglobulin E competitor
US5693756A (en) 1994-02-28 1997-12-02 The Johns Hopkins University Amiloride-sensitive sodium channel and method of identifying substances which stimulate or block salty taste perception
US5892018A (en) * 1996-04-02 1999-04-06 Welsh; Michael J. DNA sequences encoding a brain sodium channel protein
US6083986A (en) 1996-07-26 2000-07-04 Icagen, Inc. Potassium channel inhibitors
US6287859B1 (en) * 1998-08-05 2001-09-11 Centre National De La Recherche Identification, functional expression and chromosal localization of a sustained human proton-gated cation channel
AU5606500A (en) 1999-06-18 2001-01-09 Applied Imaging Corporation High efficiency methods for combined immunocytochemistry and in-situ hybridization
US7312043B2 (en) * 2000-07-10 2007-12-25 Vertex Pharmaceuticals (San Diego) Llc Ion channel assay methods
US20020128203A1 (en) * 2000-09-20 2002-09-12 Laurent Schild Methods of identifying inhibitory compounds and uses thereof
US20020168625A1 (en) * 2000-10-13 2002-11-14 Weaver Charles David Methods for detecting modulators of ion channels using thallium (I) sensitive assays
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
AU2002308481A1 (en) * 2001-05-01 2002-11-11 Senomyx, Inc. High throughput cell-based assay for monitoring sodium channel activity and discovery of salty taste modulating compounds
US7282336B2 (en) 2001-07-18 2007-10-16 Bionomics Limited Method of diagnosing epilepsy
US20070071757A1 (en) 2001-11-08 2007-03-29 Guoying Yu Novel compositions and methods in cancer
US20050037369A1 (en) 2002-10-31 2005-02-17 Neote Kuldeep Singh Panels of molecular targets differentially expressed during CD8+ T cell priming, and methods for therapy and diagnosis utilizing the same
JP2007528712A (ja) * 2003-07-10 2007-10-18 セノミックス、インコーポレイテッド ヒトＥＮａＣを発現する卵母細胞を用いた改良された電気生理学的アッセイ及び膜電位リポーター色素を用いたアッセイにおけるＥＮａＣ相乗剤の効果を向上させるためのフェナミルの使用
WO2005041684A2 (en) 2003-08-06 2005-05-12 Senomyx Inc. Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
US20060223117A1 (en) 2005-02-07 2006-10-05 Senomyx, Inc. Novel splice variants of human epithelial sodium channel genes expressed in human taste tissue and uses thereof
MX2008015314A (es) 2006-06-08 2008-12-12 Senomyx Inc Fundamentos, metodos y analisis para identificar nuevos genes de celulas del gusto y objetivos de receptores del sabor salado, y analisis que utilizan estos genes o productos genicos identificados.

Also Published As

Publication number Publication date
US20050059094A1 (en) 2005-03-17
US20120070857A1 (en) 2012-03-22
AU2004263845A1 (en) 2005-02-17
US20160069899A9 (en) 2016-03-10
CN1842709A (zh) 2006-10-04
US8105792B2 (en) 2012-01-31
US20190242905A1 (en) 2019-08-08
IL172933A0 (en) 2006-06-11
KR20060029680A (ko) 2006-04-06
WO2005014848A2 (en) 2005-02-17
US10215759B2 (en) 2019-02-26
JP2007528712A (ja) 2007-10-18
EP1644738A2 (en) 2006-04-12
US9459259B2 (en) 2016-10-04
CA2530497A1 (en) 2005-02-17
US10048274B2 (en) 2018-08-14
MXPA06000266A (es) 2006-03-30
WO2005014848A3 (en) 2005-05-06
US20170175160A1 (en) 2017-06-22
BRPI0412471A (pt) 2006-09-19
US20090123942A1 (en) 2009-05-14

Similar Documents

Publication Publication Date Title
NO20060078L (no) Forbedrede elektrofysiologiske tester som benytter oocytter som uttrykker human ENaC og anvendelse av fenamil for a forbedre effekten av ENaC-forsterkere i tester som benytter membran potensial rapporterende fargestoffer
Velez et al. A functional assay for paralytic shellfish toxins that uses recombinant sodium channels
Roe et al. Assessment of Fura-2 for measurements of cytosolic free calcium
WO2002087306A3 (en) High throughput cell-based assay for monitoring sodium channel activity and discovery of salty taste modulating compounds
Orvos et al. Evaluation of possible proarrhythmic potency: Comparison of the effect of dofetilide, cisapride, sotalol, terfenadine, and verapamil on hERG and Native I Kr currents and on cardiac action potential
Lourdel et al. A chloride channel at the basolateral membrane of the distal-convoluted tubule: a candidate ClC-K channel
Lee et al. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes
Kaczmarska et al. Erythrocyte membrane properties in patients with essential hypertension
Shi et al. Evaluation of in vitro models of stem cell-derived cardiomyocytes to screen for potential cardiotoxicity of chemicals
Chen et al. Utility of large-scale transiently transfected cells for cell-based high-throughput screens to identify transient receptor potential channel A1 (TRPA1) antagonists
EP2270493B1 (en) Method for screening olfactory sensibility inhibitor
Balasubramanian et al. Optimization of Cav1. 2 screening with an automated planar patch clamp platform
WO2010094694A1 (en) Assays to predict cardiotoxicity
Wauchop et al. Maturation of iPSC-derived cardiomyocytes in a heart-on-a-chip device enables modeling of dilated cardiomyopathy caused by R222Q-SCN5A mutation
Kojic et al. An EGFR autocrine loop encodes a slow-reacting but dominant mode of mechanotransduction in a polarized epithelium
Sánchez et al. Electrophysiological demonstration of voltage-activated H+ channels in bovine articular chondrocytes
Meany et al. Superoxide released into the mitochondrial matrix
Saegusa et al. Modulation of ventricular transient outward K+ current by acidosis and its effects on excitation-contraction coupling
Ridge et al. A large conductance, Ca2+-activated K+ channel in a human lung epithelial cell line (A549)
Chen et al. Validation and optimization of novel high-throughput assays for human epithelial sodium channels
Zou Ion channel profiling to advance drug discovery and development
Gullam et al. Phase-plot analysis of the oxytocin effect on human myometrial contractility
Marino et al. An outwardly rectifying chloride channel in BeWo choriocarcinoma cell line
Hwang et al. Cardiac melanocytes influence atrial reactive oxygen species involved with electrical and structural remodeling in mice
Kamkin et al. Identification of RNA reads encoding different channels in isolated rat ventricular myocytes and the effect of cell stretching on L-type Ca 2+ current

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application